Clinical trial
Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness
NCT03624920 is registered in ClinicalTrials.gov with Theranexus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness
- Lead sponsor
- Theranexus
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 12, 2018
- Completion date
- February 24, 2020
- Enrollment
- 77 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.